Aromatase and gynecomastia.
GD Braunstein - Endocrine-related cancer, 1999 - erc.bioscientifica.com
An imbalance between estrogen action relative to androgen action at the breast tissue level
results in gynecomastia. Enhancement of aromatization of androgens to estrogens is …
results in gynecomastia. Enhancement of aromatization of androgens to estrogens is …
46, XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency
BB Mendonca, NL Gomes, EMF Costa, M Inacio… - The Journal of steroid …, 2017 - Elsevier
Abstract 17β-hydroxysteroid dehydrogenase 3 deficiency consists of a defect in the last
phase of steroidogenesis, in which androstenedione is converted into testosterone and …
phase of steroidogenesis, in which androstenedione is converted into testosterone and …
Molecular epidemiology of hypospadias: review of genetic and environmental risk factors
JM Manson, MC Carr - Birth Defects Research Part A: Clinical …, 2003 - Wiley Online Library
Hypospadias is one of the most common congenital anomalies in the United States,
occurring in approximately 1 in 125 live male births. It is characterized by altered …
occurring in approximately 1 in 125 live male births. It is characterized by altered …
The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency
MM George, MI New, S Ten, C Sultan… - Hormone Research in …, 2010 - karger.com
β-hydroxysteroid dehydrogenase type 3 (17βHSD-3) deficiency is a rare, but frequently
misdiagnosed autosomal recessive cause of 46, XY disorder of sex development (DSD) …
misdiagnosed autosomal recessive cause of 46, XY disorder of sex development (DSD) …
Pubertal gynecomastia
C Lazala, P Saenger - Journal of Pediatric Endocrinology and …, 2002 - degruyter.com
Gynecomastia is a benign condition in males, characterized by proliferation of glandular
elements resulting in concentric enlargement of one or both breasts. During puberty, there is …
elements resulting in concentric enlargement of one or both breasts. During puberty, there is …
Gynecomastia
AR Glass - Endocrinology and metabolism clinics of North America, 1994 - Elsevier
Gynecomastia is a common disorder that generally reflects an increased effective
estrogen/androgen ratio acting on the breast. It is usually idiopathic or related to normal …
estrogen/androgen ratio acting on the breast. It is usually idiopathic or related to normal …
Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene
Production of appropriate quantities of estrogen in various tissues is essential for human
physiology. A single gene (CYP19), regulated via tissue-specific promoters, encodes the …
physiology. A single gene (CYP19), regulated via tissue-specific promoters, encodes the …
Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred
G Binder, DI Iliev, A Dufke, M Wabitsch… - The Journal of …, 2005 - academic.oup.com
Increased extraglandular aromatization has been reported to cause the rare entity of familial
gynecomastia. Recently heterozygous inversions at the p450 aromatase gene promotor …
gynecomastia. Recently heterozygous inversions at the p450 aromatase gene promotor …
Incidence and management of gynecomastia in men treated for prostate cancer
A Dobs, MJM Darkes - The Journal of urology, 2005 - Elsevier
PURPOSE:: Gynecomastia is a potentially treatment limiting adverse event in men receiving
hormone therapy for prostate cancer. MATERIALS AND METHODS:: In large, randomized …
hormone therapy for prostate cancer. MATERIALS AND METHODS:: In large, randomized …
17β-Hydroxysteroid dehydrogenase 3 deficiency
S Andersson, DW Russell, JD Wilson - Trends in Endocrinology & …, 1996 - cell.com
Five known~ s~ nzymes catalyze the 17~-hydroxyster~ id dehydrugen~ e reaction that
controls the interconversion of estrone and estradiol and of testosterone and …
controls the interconversion of estrone and estradiol and of testosterone and …